THORNBURG BETTER WORLD INTERNATIONAL FUND THORNBURG BETTER WORLD INTERNATIONAL FUND - CLASS I (TBWIX US) stock market data APIs
21.33
0(0%)
as of July 10, 2025
Try our APIs with
free plan!
THORNBURG BETTER WORLD INTERNATIONAL FUND THORNBURG BETTER WORLD INTERNATIONAL FUND - CLASS I Financial Data Overview
Price chart is built with
Anychart
Prev. Close
21.33
Open
21.33
High
21.33
Low
21.33
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get THORNBURG BETTER WORLD INTERNATIONAL FUND THORNBURG BETTER WORLD INTERNATIONAL FUND - CLASS I data using free add-ons & libraries
End-of-day & Earnings data
Get THORNBURG BETTER WORLD INTERNATIONAL FUND THORNBURG BETTER WORLD INTERNATIONAL FUND - CLASS I Earnings data
$
19.99
/mo.
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
Get THORNBURG BETTER WORLD INTERNATIONAL FUND THORNBURG BETTER WORLD INTERNATIONAL FUND - CLASS I End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
THORNBURG BETTER WORLD INTERNATIONAL FUND THORNBURG BETTER WORLD INTERNATIONAL FUND - CLASS I News
New
NeoGenomics To Participate In The Virtual Raymond James 42nd Annual Institutional Investors Conference
FT. MYERS, FL / ACCESSWIRE / March 1, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announc...
NeoGenomics To Participate In The Virtual 10th Annual SVB Leerink Global Healthcare Conference
FT. MYERS, FL / ACCESSWIRE / February 25, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today ann...
NeoGenomics Reports 18% Revenue Growth to $126 Million in the Fourth Quarter
Fourth-Quarter 2020 Results and Highlights: Consolidated revenue increased 18% to $126 million Clinical Services revenue increased 14% to $107 million Pharma Services revenue increased 43% to $19 mi...
NeoGenomics Announces CEO Succession
Mark Mallon named CEO effective April 2021; Douglas M. VanOort will retire as CEO and transition to executive chairman of the board of directors FT. MYERS, FL / ACCESSWIRE / February 24, 2021 / NeoGe...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
